Truffle Capital floats Carmat

800,000 new shares have been issued, representing 22.15% of the company's capital. Shares have an indicative price range of €17.35 to €20.15. The gross proceeds from the issue could be increased to €17.3m should the entire extension clause be exercised, and to €19.8m should both the entire extension clause and entire overallotment option be exercised (based on the mean price range value of €18.75).

Truffle Capital, the main shareholder of Carmat, is bound to keep its stake for at least 180 days following the first listing.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Grégoire Gille on +44 20 7484 9824 or gregoire.gille@incisivemedia.com

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Benelux
• UK / Ireland
• Nordics
• DACH
• Southern Europe
• CEE
• Exits
• Healthcare
• France
• NYSE
• Euronext